[1]
Y. . Teng, R. . Guo, J. . Sun, and Y. . Liu, “Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent”, AO, vol. 58, no. 3, pp. 388–389, Mar. 2019.